β¨ Medicines Consent
NEW ZEALAND GAZETTE, No. 39
1 APRIL 2004
Avandia
Product:
Active Ingredient: Rosiglitazone maleate 10.6mg equivalent to 8mg rosiglitazone
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico
Cancidas
Product:
Active Ingredient: Caspofungin acetate 57.8mg equivalent to 50mg caspofungin anhydrous free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Sumneytown Pike, West Point, Pennsylvania, United States of America
Cancidas
Product:
Active Ingredient: Caspofungin acetate 60.6mg equivalent to 50mg caspofungin anhydrous free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Sumneytown Pike, West Point, Pennsylvania, United States of America
Cancidas
Product:
Active Ingredient: Caspofungin acetate 83.9mg equivalent to 70mg caspofungin anhydrous free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Sumneytown Pike, West Point, Pennsylvania, United States of America
Dysport
Product:
Active Ingredient: Clostridium botulinum type A toxin haemagglutinin complex 500U
Dosage Form: Powder for injection
New Zealand Sponsor: New Zealand Medical & Scientific Limited
Manufacturer: Ispen Limited, Wrexham Industrial Estate, Clwyd, United Kingdom
Enbrel
Product:
Active Ingredient: Etanercept 25mg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Lipitor
Product:
Active Ingredient: Atorvastatin calcium 10.85mg equivalent to 10mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers:
- Godecke GmbH, Freiburg, Germany
- Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
- Parke-Davis, Angers Cedex, France
- Pfizer Ireland Pharmaceuticals, Ringaskiddy, County Cork, Ireland
- Warner-Lambert Company, Lititz, Pennsylvania, United States of America
Lipitor
Product:
Active Ingredient: Atorvastatin calcium 21.69mg equivalent to 20mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers:
- Godecke GmbH, Freiburg, Germany
- Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
- Parke-Davis, Angers Cedex, France
- Pfizer Ireland Pharmaceuticals, Ringaskiddy, County Cork, Ireland
- Warner-Lambert Company, Lititz, Pennsylvania, United States of America
Lipitor
Product:
Active Ingredient: Atorvastatin calcium 43.38mg equivalent to 40mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers:
- Godecke GmbH, Freiburg, Germany
- Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
- Parke-Davis, Angers Cedex, France
- Pfizer Ireland Pharmaceuticals, Ringaskiddy, County Cork, Ireland
- Warner-Lambert Company, Lititz, Pennsylvania, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 39
Gazette.govt.nz —
NZ Gazette 2004, No 39
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social Welfare29 March 2004
Medicines, Consent, Changed, Avandia, Cancidas, Dysport, Enbrel, Lipitor